IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $341,000 | +16.8% | 17,519 | 0.0% | 0.01% | +14.3% |
| Q4 2017 | $292,000 | -77.4% | 17,519 | -72.5% | 0.01% | -75.9% |
| Q3 2017 | $1,293,000 | +29.8% | 63,700 | +2.9% | 0.03% | +31.8% |
| Q2 2017 | $996,000 | -33.3% | 61,879 | -47.6% | 0.02% | -33.3% |
| Q1 2017 | $1,493,000 | +497.2% | 118,063 | +526.6% | 0.03% | +450.0% |
| Q4 2016 | $250,000 | -44.1% | 18,841 | 0.0% | 0.01% | -40.0% |
| Q3 2016 | $447,000 | -65.2% | 18,841 | -31.2% | 0.01% | -60.0% |
| Q1 2015 | $1,284,000 | -49.7% | 27,400 | -66.0% | 0.02% | -46.8% |
| Q4 2014 | $2,553,000 | – | 80,590 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |